139 related articles for article (PubMed ID: 37611264)
1. Guillain-Barré Syndrome and COVID-19 Vaccine: A Multicenter Retrospective Study of 46 Cases.
Castiglione JI; Crespo JM; Bendersky M; Silveira FO; Lecchini L; Luis MB; Zambrano FC; Cotti N; Simison CJ; Aguirre F; Piedrabuena MA; Alonso RN; Azcona CL; Sosa PS; Maldonado E; Varela F; Bettini M; Rey RD; Cejas LL; Rugiero M; Reisin R; Barroso F
J Clin Neuromuscul Dis; 2023 Sep; 25(1):1-10. PubMed ID: 37611264
[TBL] [Abstract][Full Text] [Related]
2. Bilateral facial palsy with paresthesias, variant of Guillain-Barré syndrome following COVID-19 vaccine: A case series of 9 patients.
Castiglione JI; Crespo JM; Lecchini L; Silveira FO; Luis MB; Cotti N; Simison CJ; Aguirre F; Piedrabuena MA; Alonso RN; Azcona CL; Sosa PS; Maldonado E; Barroso F
Neuromuscul Disord; 2022 Jul; 32(7):572-574. PubMed ID: 35644722
[TBL] [Abstract][Full Text] [Related]
3. Bilateral facial palsy after COVID-19 vaccination.
Andreozzi V; D'arco B; Pagliano P; Toriello A; Barone P
Neurol Sci; 2022 Jul; 43(7):4069-4079. PubMed ID: 35364768
[TBL] [Abstract][Full Text] [Related]
4. Guillain-Barré syndrome after COVID-19 vaccination: A systematic review and analysis of case reports.
Abuawwad MT; Taha MJJ; Taha AJ; Kozaa YA; Falah O; Abuawwad IT; Hammad EM; Mahmoud AA; Aladawi M; Serhan HA
Clin Neurol Neurosurg; 2024 Mar; 238():108183. PubMed ID: 38401232
[TBL] [Abstract][Full Text] [Related]
5. Guillain-Barré syndrome after COVID-19 vaccines: A Tunisian case series.
Berrim K; Lakhoua G; Zaiem A; Charfi O; Aouinti I; Kastalli S; Daghfous R; El Aidli S
Br J Clin Pharmacol; 2023 Feb; 89(2):574-578. PubMed ID: 36398559
[TBL] [Abstract][Full Text] [Related]
6. Incidence of Guillain-Barré Syndrome After COVID-19 Vaccination in the Vaccine Safety Datalink.
Hanson KE; Goddard K; Lewis N; Fireman B; Myers TR; Bakshi N; Weintraub E; Donahue JG; Nelson JC; Xu S; Glanz JM; Williams JTB; Alpern JD; Klein NP
JAMA Netw Open; 2022 Apr; 5(4):e228879. PubMed ID: 35471572
[TBL] [Abstract][Full Text] [Related]
7. Guillain-Barre syndrome following COVID-19 vaccines: A review of literature.
Yu M; Nie S; Qiao Y; Ma Y
Front Immunol; 2023; 14():1078197. PubMed ID: 36875094
[TBL] [Abstract][Full Text] [Related]
8. Reports of Guillain-Barré Syndrome After COVID-19 Vaccination in the United States.
Abara WE; Gee J; Marquez P; Woo J; Myers TR; DeSantis A; Baumblatt JAG; Woo EJ; Thompson D; Nair N; Su JR; Shimabukuro TT; Shay DK
JAMA Netw Open; 2023 Feb; 6(2):e2253845. PubMed ID: 36723942
[TBL] [Abstract][Full Text] [Related]
9. COVID-19 vaccination and Guillain-Barré syndrome: analyses using the National Immunoglobulin Database.
Keh RYS; Scanlon S; Datta-Nemdharry P; Donegan K; Cavanagh S; Foster M; Skelland D; Palmer J; Machado PM; Keddie S; Carr AS; Lunn MP;
Brain; 2023 Feb; 146(2):739-748. PubMed ID: 35180300
[TBL] [Abstract][Full Text] [Related]
10. A Clinical Case of COVID-19 Vaccine-Associated Guillain-Barré Syndrome.
Hilts A; Schreiber A; Singh A
Am J Case Rep; 2022 Aug; 23():e936896. PubMed ID: 35945825
[TBL] [Abstract][Full Text] [Related]
11. Rare cases of Guillain-Barré syndrome after COVID-19 vaccination, Germany, December 2020 to August 2021.
Lehmann HC; Oberle D; Keller-Stanislawski B; Rieck T; Streit R
Euro Surveill; 2023 Jun; 28(24):. PubMed ID: 37318764
[TBL] [Abstract][Full Text] [Related]
12. Effects of COVID-19 vaccine type on Guillain-Barré syndrome: Two cases and a literature review.
Lee HY; Lien WC
Hum Vaccin Immunother; 2023 Dec; 19(1):2171231. PubMed ID: 36919452
[TBL] [Abstract][Full Text] [Related]
13. COVID-19 vaccine-related Guillain-Barré syndrome in the Liguria region of Italy: A multicenter case series.
Germano F; Bellucci M; Grisanti S; Beronio A; Grazzini M; Coco E; Tassinari T; Della Cava F; De Michelis C; Baldi O; Sivori G; Murialdo A; Cabona C; Durando P; Uccelli A; Schenone A; Franciotta D; Benedetti L
J Neurol Sci; 2022 Sep; 440():120330. PubMed ID: 35802961
[TBL] [Abstract][Full Text] [Related]
14. AstraZeneca COVID-19 vaccine and Guillain- Barré Syndrome in Tasmania: A causal link?
Oo WM; Giri P; de Souza A
J Neuroimmunol; 2021 Nov; 360():577719. PubMed ID: 34560365
[TBL] [Abstract][Full Text] [Related]
15. Guillain-Barré syndrome in association with COVID-19 vaccination: a systematic review.
Abolmaali M; Rezania F; Behnagh AK; Hamidabad NM; Gorji A; Mirzaasgari Z
Immunol Res; 2022 Dec; 70(6):752-764. PubMed ID: 36098903
[TBL] [Abstract][Full Text] [Related]
16. Guillain-Barré syndrome is infrequent among recipients of the BNT162b2 mRNA COVID-19 vaccine.
García-Grimshaw M; Michel-Chávez A; Vera-Zertuche JM; Galnares-Olalde JA; Hernández-Vanegas LE; Figueroa-Cucurachi M; Paredes-Ceballos O; Reyes-Terán G; Carbajal-Sandoval G; Ceballos-Liceaga SE; Arauz A; Valdés-Ferrer SI
Clin Immunol; 2021 Sep; 230():108818. PubMed ID: 34358692
[TBL] [Abstract][Full Text] [Related]
17. Guillain-Barré syndrome after AstraZeneca COVID-19-vaccination: A causal or casual association?
Introna A; Caputo F; Santoro C; Guerra T; Ucci M; Mezzapesa DM; Trojano M
Clin Neurol Neurosurg; 2021 Sep; 208():106887. PubMed ID: 34418708
[TBL] [Abstract][Full Text] [Related]
18. Associations of Guillain-Barré syndrome with coronavirus disease 2019 vaccination: Disproportionality analysis using the World Health Organization pharmacovigilance database.
Kim JE; Park J; Min YG; Hong YH; Song TJ
J Peripher Nerv Syst; 2022 Sep; 27(3):206-214. PubMed ID: 35751472
[TBL] [Abstract][Full Text] [Related]
19. Association of Receipt of the Ad26.COV2.S COVID-19 Vaccine With Presumptive Guillain-Barré Syndrome, February-July 2021.
Woo EJ; Mba-Jonas A; Dimova RB; Alimchandani M; Zinderman CE; Nair N
JAMA; 2021 Oct; 326(16):1606-1613. PubMed ID: 34617967
[TBL] [Abstract][Full Text] [Related]
20. Guillain-Barré syndrome temporally associated with COVID-19 vaccines in Victoria, Australia.
Osowicki J; Morgan HJ; Harris A; Clothier HJ; Buttery JP; Kiers L; Crawford NW;
Vaccine; 2022 Dec; 40(52):7579-7585. PubMed ID: 36357291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
